Suzumura A, Silberberg D H, Lisak R P
J Neuroimmunol. 1986 May;11(3):179-90. doi: 10.1016/0165-5728(86)90002-0.
Neither class I nor class II major histocompatibility complex (MHC) antigen has been demonstrated in native oligodendrocytes, the possible target of viral or immune damage in multiple sclerosis (MS). In this report, we show that H-2, but not Ia, antigen expression is induced on isolated mouse oligodendrocytes in vitro by crude supernatant from lectin-activated spleen cells, lectin-free interleukin 2, and cloned gamma-interferon. This induction of H-2 expression is not accompanied by proliferation of oligodendrocytes, whereas MHC induction in spleen cells is highly related to their proliferation, or blastoid transformation. Oligodendrocytes as well as other brain cells are probably isolated from these lymphokines by the blood-brain barrier (BBB). However, it is possible that oligodendrocytes express MHC class I antigen as a consequence of impairment of the BBB, or in the presence of activated T-cells which have been demonstrated in active MS lesions. This activation then renders oligodendrocytes possible target cells for MHC-restricted cytotoxic T-cells.
在天然少突胶质细胞中,尚未证实有I类或II类主要组织相容性复合体(MHC)抗原,而少突胶质细胞可能是多发性硬化症(MS)中病毒或免疫损伤的靶细胞。在本报告中,我们表明,来自凝集素激活的脾细胞的粗提上清液、无凝集素的白细胞介素2和克隆的γ干扰素可在体外诱导分离的小鼠少突胶质细胞表达H-2抗原,但不表达Ia抗原。这种H-2表达的诱导并不伴随着少突胶质细胞的增殖,而脾细胞中的MHC诱导与其增殖或母细胞样转化高度相关。少突胶质细胞以及其他脑细胞可能通过血脑屏障(BBB)与这些淋巴因子隔离。然而,少突胶质细胞有可能由于血脑屏障受损或在活动性MS病变中已证实存在的活化T细胞的存在而表达MHC I类抗原。这种激活进而使少突胶质细胞成为MHC限制性细胞毒性T细胞的潜在靶细胞。